Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin-Reference-Cited by-同舟云学术

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Published:2013-01 Issue:1 Volume:53 Page:75-81
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:J Clin Pharmacol

Author:

Kim Jung Won¹,Yi SoJeong¹,Kim Tae-Eun¹,Lim Kyoung Soo¹,Yoon Seo Hyun¹,Cho Joo-Youn¹,Lee Min Goo²,Song Im-Sook³,Shin Sang-Goo¹,Jang In-Jin¹,Yu Kyung-Sang¹

Affiliation:

1. Seoul National University College of Medicine and Hospital; Seoul; Korea

2. Yonsei University College of Medicine; Seoul; Korea

3. Inje University College of Medicine; Busan; Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011433328/fullpdf

Reference24 articles.

1. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers;Yi;J Cardiovasc Pharmacol,2011

2. The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers;Shin;J Cardiovasc Pharmacol,2011

3. Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers;Yi;Int J Clin Pharmacol Ther,2011

4. Single dose pharmacokinetics (PK) and pharmacodynamics (PD) of BR-A-657, an angiotensin II (AII) antagonist;Lane;Clin Pharmacol Ther,2005

5. Multiple dose pharmacokinetics (PK) and pharmacodynamics (PD) of BR-A-657, an angiotensin II (AII) antagonist;Lane;Clin Pharmacol Ther,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023;Drug Metabolism and Disposition;2023-07-05

2. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography–tandem mass spectrometry method utilizing electrospray ionization in positive mode;Biomedical Chromatography;2020-09-18

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

;Drug Design, Development and Therapy;2020-05

4. Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2020-04

5. Progress in the Consideration of Possible Sex Differences in Drug Interaction Studies;Current Drug Metabolism;2019-04-30